| 1 |
28664942 | Darunavir Stands Up as Preferred HIV Protease Inhibitor. | 2017 Apr - Jun |
1 |
| 2 |
26035169 | Rezolsta® (Darunavir/Cobicistat): First Boosted Protease Inhibitor Co-formulated with Cobicistat. | 2015 Apr-Jun |
4 |
| 3 |
23956848 | Comparative Effectiveness of Darunavir 1,200 mg Daily and Approved Dosing Strategies for Protease Inhibitor-Experienced Patients. | 2013 |
1 |
| 4 |
21692667 | Darunavir: an effective protease inhibitor for HIV-infected patients. | 2011 Jun |
2 |
| 5 |
19587054 | The impact of individual human immunodeficiency virus type 1 protease mutations on drug susceptibility is highly influenced by complex interactions with the background protease sequence. | 2009 Sep |
1 |
| 6 |
15905675 | TMC114/ritonavir substitution for protease inhibitor(s) in a non-suppressive antiretroviral regimen: a 14-day proof-of-principle trial. | 2005 Jun 10 |
2 |